Literature DB >> 15638877

A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients.

Cherie Y Chiang1, David G Andrewes, Dianne Anderson, Michael Devere, Isaac Schweitzer, Jeffrey D Zajac.   

Abstract

BACKGROUND: There is an increasing number of primary hyperparathyroidism (PHPT) patients with neuropsychological or psychiatric symptoms. Many of these patients do not have osseous or renal complications to satisfy the criteria for parathyroidectomy according to the NIH guidelines.
OBJECTIVE: To assess whether there is any improvement in neuropsychological and mood symptoms following parathyroidectomy. PATIENTS AND
DESIGN: Twenty PHPT patients undergoing parathyroidectomy and 20 orthopaedic controls matched for age, gender and estimated intelligence were subjects to pre and postoperative assessment of cognition and mood with a mean surgery-retest interval of 3 months.
RESULTS: Using two tests of attentional flexibility [the Stroop test, the Digit symbol test of the Wechsler Adult Intelligence Scale-Revised (WAIS-R)], and two memory tests for prose and nonverbal material, no significant change was found between the groups when comparing scores before and after surgery. There was no improvement between pre and postoperative measures of verbal (dominant hemisphere) as opposed to visuo-spatial (nondominant hemisphere) function when compared to controls. There was no relationship between the reduction in serum calcium and the change in the neuropsychological measures postoperatively.
CONCLUSION: This controlled, prospective study demonstrates no significant improvement in neuropsychological indices using objective, validated psychometric tools in an unselected cohort of PHPT patients. No relationship was found between serum calcium level and the degree of neuropsychological deficit. More studies are needed to assess whether the effect of parathyroidectomy is beneficial and sustainable in PHPT patients with neuropsychological symptoms alone.

Entities:  

Mesh:

Year:  2005        PMID: 15638877     DOI: 10.1111/j.1365-2265.2004.02180.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  New perspectives in the management of primary hyperparathyroidism.

Authors:  John Ayuk; Mark S Cooper; Neil J L Gittoes
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

Review 2.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

Review 4.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 5.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 6.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

7.  Functional magnetic resonance imaging in primary hyperparathyroidism.

Authors:  Yunglin Gazes; Minghao Liu; Melissa Sum; Elaine Cong; Jennifer Kuo; James A Lee; Shonni Silverberg; Yaakov Stern; Marcella Walker
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

8.  Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism.

Authors:  Ann E Kearns; Rachel P Espiritu; Kristin Vickers Douglass; Prabin Thapa; Robert A Wermers
Journal:  Clin Endocrinol (Oxf)       Date:  2019-06-25       Impact factor: 3.523

9.  Neuropsychological features in primary hyperparathyroidism: a prospective study.

Authors:  Marcella D Walker; Donald J McMahon; William B Inabnet; Ronald M Lazar; Ijeoma Brown; Susan Vardy; Felicia Cosman; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

10.  Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.

Authors:  Theresia Weber; Monika Keller; Isabella Hense; Alexander Pietsch; Ulf Hinz; Tobias Schilling; Peter Nawroth; Ernst Klar; Markus W Büchler
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.